Fatigue and fatigability in neurologic illnesses: proposal for a unified taxonomy

BM Kluger, LB Krupp, RM Enoka - Neurology, 2013 - AAN Enterprises
Fatigue is commonly reported in many neurologic illnesses, including multiple sclerosis,
Parkinson disease, myasthenia gravis, traumatic brain injury, and stroke. Fatigue contributes …

Palliative care and neurology: time for a paradigm shift

I Boersma, J Miyasaki, J Kutner, B Kluger - Neurology, 2014 - AAN Enterprises
Palliative care is an approach to the care of patients and families facing progressive and
chronic illnesses that focuses on the relief of suffering due to physical symptoms, psychosocial …

Nonmotor manifestations of dystonia: a systematic review

…, V Parra, S Aerts, MS Okun, BM Kluger - Movement …, 2011 - Wiley Online Library
Kluger contributed to the conception, organization, and execution of the research project …
Benzi Kluger has received compensation for speaking from Teva Neuroscience. Dr. Michael …

Effect of high-intensity treadmill exercise on motor symptoms in patients with de novo Parkinson disease: a phase 2 randomized clinical trial

…, CL Christiansen, BD Berman, BM Kluger… - JAMA …, 2018 - jamanetwork.com
B, Mean days exercised for each intervention group across weeks 9 to 26. In A and B,
symbols represent the means and bars are the SEs. Trends over time were tested using linear …

Identification and profiling of volatile metabolites of the biocontrol fungus Trichoderma atroviride by HS-SPME-GC-MS

N Stoppacher, B Kluger, S Zeilinger, R Krska… - Journal of …, 2010 - Elsevier
In the present study we describe a method, which is based on solid phase microextraction (SPME)
coupled to gas chromatography–mass spectrometry (GC-MS) and which can be used …

The therapeutic potential of cannabinoids for movement disorders

B Kluger, P Triolo, W Jones, J Jankovic - Movement disorders, 2015 - Wiley Online Library
The therapeutic potential of cannabinoids for movement disorders - Kluger - 2015 - … Group
B started with placebo for 7 days, crossed to the active period (14 days) and a 3-day placebo …

Compensatory neural activity in response to cognitive fatigue

…, IBH Samuel, M Ding, BM Kluger - Journal of …, 2016 - Soc Neuroscience
B, Results of statistical tests on changes of GFP waveforms over time blocks. The dash
line indicates p = 0.1. Evoked periods with p < 0.1 are shaded in Figure 2A and selected for …

Neuropalliative care: priorities to move the field forward

CJ Creutzfeldt, B Kluger, AG Kelly, M Lemmon… - Neurology, 2018 - AAN Enterprises
Neuropalliative care is an emerging subspecialty in neurology and palliative care. On April
26, 2017, we convened a Neuropalliative Care Summit with national and international …

Comparison of integrated outpatient palliative care with standard care in patients with Parkinson disease and related disorders: a randomized clinical trial

BM Kluger, J Miyasaki, M Katz, N Galifianakis… - JAMA …, 2020 - jamanetwork.com
Importance Parkinson disease and related disorders (PDRD) have consequences for quality
of life (QoL) and are the 14th leading cause of death in the United States. Despite growing …

Safety of transcranial magnetic stimulation in children: a systematic review of the literature

CH Allen, BM Kluger, I Buard - Pediatric neurology, 2017 - Elsevier
Background Data and best practice recommendations for transcranial magnetic stimulation (TMS)
use in adults are largely available. Although there are fewer data in pediatric …